James Jiqi Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Inflammatory Response

Pulmonary Arterial Hypertension

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

James Jiqi Wang, Sanshan Jin, Heng Zhang, Youwei Xu, Wen Hu, Yi Jiang, Chen Chen, Dao-Wen Wang, H Eric Xu, Canrong Wu
Molecular recognition and activation of the prostacyclin receptor by anti-pulmonary arterial hypertension drugs. Science advances 10 (6) (2024)
James Jiqi Wang, Sanshan Jin, Heng Zhang, Youwei Xu, Wen Hu, Yi Jiang, Chen Chen, Dao-Wen Wang, H Eric Xu, Canrong Wu
Molecular recognition and activation of the prostacyclin receptor by anti-pulmonary arterial hypertension drugs. Science advances 10 (6) (2024)
James Jiqi Wang, Sanshan Jin, Heng Zhang, Youwei Xu, Wen Hu, Yi Jiang, Chen Chen, Dao-Wen Wang, H Eric Xu, Canrong Wu
Molecular recognition and activation of the prostacyclin receptor by anti-pulmonary arterial hypertension drugs. Science advances 10 (6) (2024)
James Jiqi Wang, Sanshan Jin, Heng Zhang, Youwei Xu, Wen Hu, Yi Jiang, Chen Chen, Dao-Wen Wang, H Eric Xu, Canrong Wu
Molecular recognition and activation of the prostacyclin receptor by anti-pulmonary arterial hypertension drugs. Science advances 10 (6) (2024)
James Jiqi Wang, Sanshan Jin, Heng Zhang, Youwei Xu, Wen Hu, Yi Jiang, Chen Chen, Dao-Wen Wang, H Eric Xu, Canrong Wu
Molecular recognition and activation of the prostacyclin receptor by anti-pulmonary arterial hypertension drugs. Science advances 10 (6) (2024)
James Jiqi Wang, Sanshan Jin, Heng Zhang, Youwei Xu, Wen Hu, Yi Jiang, Chen Chen, Dao-Wen Wang, H Eric Xu, Canrong Wu
Molecular recognition and activation of the prostacyclin receptor by anti-pulmonary arterial hypertension drugs. Science advances 10 (6) (2024)
James Jiqi Wang, Bo Yu, Yang Sun, Xiuli Song, Dao Wen Wang, Zongzhe Li
FBN1 Splice-Altering Mutations in Marfan Syndrome: A Case Report and Literature Review. Genes 13 (10) (2022)